The future for global advanced therapy shipments requiring critical chain of custody, chain of condition and Chain of Compliance® near real-time reporting are facing a significant technology change.
In February 2022, 2G/3G networks are sunsetting in the United States and immediately transitioning to only leveraging 4G/LTE networks. Other countries and regions will continue to leverage 2G/3G networks and will decommission them at different rates.
The global shift towards 4G/LTE networks and moving away from 2G/3G is not without its complications. As networks continue to decommission 2G/3G networks globally, technology challenges relating to capacity and connectivity will impact all carrier services as well as packaging technology providers.
Join Cryoport Systems’ free webinar to learn about the upcoming network transitions, the associated challenges with the technology changes, and how you can ensure the certainty of global coverage and data fidelity for your cell and gene therapy shipments.
Topics in this presentation include:
North America’s Global Cellular Network Background and Current Status
Current State of the Supply Chain for High Technology Components Globally
Government, Aircraft, and Country Changes to Meet Regulatory Requirements
Next Generation Solutions for Logistics and Monitoring to meet Cell and Gene Therapy Industry Needs